SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-003663
Filing Date
2020-03-10
Accepted
2020-03-10 16:06:11
Documents
1
Period of Report
2020-03-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4042
  Complete submission text file 0001493152-20-003663.txt   5437
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10016
Business Address
Salzmann Peter (Reporting) CIK: 0001796309 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 20701569